Nonfatal Graft-versus-host Disease Occurring After Transfusion with Leukocytes and Platelets Obtained from Normal Donors
Overview
Authors
Affiliations
There have been two previous reports of fatal graft-versus-host (GVH) disease following transfusion of leukocytes from normal donors for the supportive care of leukemic patients. We have reported a nonfatal case of GVH disease in a child with acute monoblastic leukemia who received leukocyte and platelet transfusions from normal donors. The dose of lymphocytes contained in both leukocyte and platelet concentrates obtained with a semicontinuous-flow cell separator is sufficient to cause GVH disease. Irradiation of all blood products administered to severely immunocompromised and myelosuppressed patients should be considered.
Transfusion-Associated Graft-Versus-Host Disease with a Non-fatal Course.
Gupta S, Sehgal T, Sachdeva M, Naseem S, Das R, Nada R Indian J Hematol Blood Transfus. 2016; 32(Suppl 1):326-8.
PMID: 27408427 PMC: 4925566. DOI: 10.1007/s12288-016-0677-8.
Irradiation in the prevention of transfusion associated graft-versus-host disease.
Webb D Arch Dis Child. 1995; 73(5):388-9.
PMID: 8554351 PMC: 1511357. DOI: 10.1136/adc.73.5.388.
Fatal graft-versus-host reaction following granulocyte transfusions.
Schmidmeier W, Feil W, Gebhart W, Grisold W, Gschnait F, Hinterberger W Blut. 1982; 45(2):115-9.
PMID: 7104497 DOI: 10.1007/BF00319939.
Two cases of graft-versus-host disease following transfusion of nonirradiated blood products.
Schmitz N, Kayser W, Gassmann W, Huhn A, Kruger G, SACHS V Blut. 1982; 44(2):83-8.
PMID: 6949620 DOI: 10.1007/BF00320094.
Graft-versus-host disease following blood transfusions.
Pflieger H Blut. 1983; 46(2):61-6.
PMID: 6600405 DOI: 10.1007/BF00320659.